AVTE
Price
$2.58
Change
+$0.15 (+6.17%)
Updated
Jan 17 closing price
Capitalization
74.59M
67 days until earnings call
HALO
Price
$54.80
Change
-$0.57 (-1.03%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
6.97B
38 days until earnings call
Ad is loading...

AVTE vs HALO

Header iconAVTE vs HALO Comparison
Open Charts AVTE vs HALOBanner chart's image
Aerovate Therapeutics
Price$2.58
Change+$0.15 (+6.17%)
Volume$249.88K
Capitalization74.59M
Halozyme Therapeutics
Price$54.80
Change-$0.57 (-1.03%)
Volume$10.96K
Capitalization6.97B
AVTE vs HALO Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. HALO commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Hold and HALO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (AVTE: $2.43 vs. HALO: $55.37)
Brand notoriety: AVTE and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 44% vs. HALO: 85%
Market capitalization -- AVTE: $74.59M vs. HALO: $6.97B
AVTE [@Biotechnology] is valued at $74.59M. HALO’s [@Biotechnology] market capitalization is $6.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than AVTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 4 TA indicator(s) are bullish while HALO’s TA Score has 4 bullish TA indicator(s).

  • AVTE’s TA Score: 4 bullish, 6 bearish.
  • HALO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HALO is a better buy in the short-term than AVTE.

Price Growth

AVTE (@Biotechnology) experienced а -7.95% price change this week, while HALO (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

AVTE is expected to report earnings on May 19, 2025.

HALO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($6.97B) has a higher market cap than AVTE($74.6M). HALO YTD gains are higher at: 15.813 vs. AVTE (-8.302). HALO has higher annual earnings (EBITDA): 580M vs. AVTE (-89.96M). HALO has more cash in the bank: 666M vs. AVTE (88.7M). AVTE has less debt than HALO: AVTE (540K) vs HALO (1.5B). HALO has higher revenues than AVTE: HALO (947M) vs AVTE (0).
AVTEHALOAVTE / HALO
Capitalization74.6M6.97B1%
EBITDA-89.96M580M-16%
Gain YTD-8.30215.813-53%
P/E RatioN/A18.15-
Revenue0947M-
Total Cash88.7M666M13%
Total Debt540K1.5B0%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTEHALO
RSI
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
64%
Momentum
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
74%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 19 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
64%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
-1.42%
OVID - AVTE
90%
Closely correlated
-4.17%
NTLA - AVTE
47%
Loosely correlated
-2.99%
DNLI - AVTE
43%
Loosely correlated
+0.79%
BEAM - AVTE
41%
Loosely correlated
+0.04%
SNDX - AVTE
39%
Loosely correlated
+1.56%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with IDYA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+1.58%
IDYA - HALO
36%
Loosely correlated
-2.32%
AVTE - HALO
35%
Loosely correlated
-1.42%
VIR - HALO
35%
Loosely correlated
-4.29%
EYEN - HALO
35%
Loosely correlated
+0.15%
UTHR - HALO
34%
Loosely correlated
+1.31%
More